Cargando…
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
The presence of mutations in the KRAS gene is a predictor of a poor clinical response to EGFR-targeted agents in patients affected by colorectal cancer (CRC), but its significance as a global prognostic factor remains unclear. The aim of the present study was to evaluate the impact of the KRAS mutat...
Autores principales: | Palomba, Grazia, Cossu, Antonio, Paliogiannis, Panagiotis, Pazzola, Antonio, Baldino, Giovanni, Scartozzi, Mario, Ionta, Maria Teresa, Ortu, Salvatore, Capelli, Francesca, Lanzillo, Annamaria, Sedda, Tito, Sanna, Giovanni, Barca, Michela, Virdis, Luciano, Budroni, Mario, Palmieri, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950545/ https://www.ncbi.nlm.nih.gov/pubmed/27446446 http://dx.doi.org/10.3892/ol.2016.4798 |
Ejemplares similares
-
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
por: Palomba, Grazia, et al.
Publicado: (2016) -
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
por: Palomba, Grazia, et al.
Publicado: (2012) -
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
por: Colombino, Maria, et al.
Publicado: (2019) -
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors
por: Palomba, Grazia, et al.
Publicado: (2020) -
KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma
por: PALIOGIANNIS, PANAGIOTIS, et al.
Publicado: (2014)